Biosyntech Financial Statements From 2010 to 2025
Biosyntech's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Biosyntech's valuation are provided below:Biosyntech does not presently have any fundamental signals for analysis.
This module can also supplement various Biosyntech Technical models . Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in private.
Check Biosyntech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Biosyntech's main balance sheet or income statement drivers, such as , as well as many indicators such as . Biosyntech financial statements analysis is a perfect complement when working with Biosyntech Valuation or Volatility modules.
Biosyntech |
Biosyntech Company Shares Outstanding Analysis
Biosyntech's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Biosyntech Shares Outstanding | 116.44 M |
Most of Biosyntech's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Biosyntech is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
CompetitionBased on the latest financial disclosure, Biosyntech has 116.44 M of shares currently outstending. This is 35.5% lower than that of the Biotechnology sector and 8.97% higher than that of the Health Care industry. The shares outstanding for all United States stocks is 79.64% higher than that of the company.
Biosyntech Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Biosyntech's current stock value. Our valuation model uses many indicators to compare Biosyntech value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Biosyntech competition to find correlations between indicators driving Biosyntech's intrinsic value. More Info.Biosyntech is rated third in return on asset category among its peers. It is rated fourth in operating margin category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Biosyntech by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Biosyntech's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Biosyntech Financial Statements
Investors use fundamental indicators, such as Biosyntech's revenue or net income, to determine how well the company is positioned to perform in the future. Although Biosyntech's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
BioSyntech, Inc. develops biotherapeutic thermogels for tissue repair and therapeutic delivery. On May 12, 2010, Biosyntech Inc. filed for administration under the Bankruptcy and Insolvency Act. BIOSYNTECH INC is traded on PNK Exchange in the United States.
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in private. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Consideration for investing in Biosyntech Pink Sheet
If you are still planning to invest in Biosyntech check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Biosyntech's history and understand the potential risks before investing.
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |